Review



ace2 inhibitor mln4760  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Tocris ace2 inhibitor mln4760
    Ace2 Inhibitor Mln4760, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2+inhibitor+mln4760/MLN+4760/pm39715591-294-38-50
    Average 94 stars, based on 3 article reviews
    ace2 inhibitor mln4760 - by Bioz Stars, 2026-09
    94/100 stars

    Images



    Similar Products

    95
    MedChemExpress ace2 inhibitor mln4760
    A: Serum ACE (nanomolar, nM) was lower in NRS and HRS groups as compared with controls. B: Serum <t>ACE2</t> content (nM) was higher in the HRS group as compared with controls. C: Serum ACE:ACE2 ratios are lower in NRS and HRS groups as compared with controls. D: Serum DPP3 levels (nM) were higher in the NRS and HRS groups as compared with controls. Statistical comparisons by one-way ANOVA with Tukey’s ( A,B ) or Kruskal-Wallis ( C,D ) post hoc tests among all groups.
    Ace2 Inhibitor Mln4760, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2+inhibitor+mln4760/MLN-4760/pmc12053747-29-16-19
    Average 95 stars, based on 1 article reviews
    ace2 inhibitor mln4760 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    94
    Tocris ace2 inhibitor mln4760
    A: Serum ACE (nanomolar, nM) was lower in NRS and HRS groups as compared with controls. B: Serum <t>ACE2</t> content (nM) was higher in the HRS group as compared with controls. C: Serum ACE:ACE2 ratios are lower in NRS and HRS groups as compared with controls. D: Serum DPP3 levels (nM) were higher in the NRS and HRS groups as compared with controls. Statistical comparisons by one-way ANOVA with Tukey’s ( A,B ) or Kruskal-Wallis ( C,D ) post hoc tests among all groups.
    Ace2 Inhibitor Mln4760, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2+inhibitor+mln4760/MLN+4760/pm39715591-294-38-50
    Average 94 stars, based on 1 article reviews
    ace2 inhibitor mln4760 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    AnaSpec ace2 inhibitor mln4760
    A: Serum ACE (nanomolar, nM) was lower in NRS and HRS groups as compared with controls. B: Serum <t>ACE2</t> content (nM) was higher in the HRS group as compared with controls. C: Serum ACE:ACE2 ratios are lower in NRS and HRS groups as compared with controls. D: Serum DPP3 levels (nM) were higher in the NRS and HRS groups as compared with controls. Statistical comparisons by one-way ANOVA with Tukey’s ( A,B ) or Kruskal-Wallis ( C,D ) post hoc tests among all groups.
    Ace2 Inhibitor Mln4760, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2+inhibitor+mln4760/sensolyte+390+ace2+activity+assay+kit/pm37858626-52-31-39
    Average 90 stars, based on 1 article reviews
    ace2 inhibitor mln4760 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    A: Serum ACE (nanomolar, nM) was lower in NRS and HRS groups as compared with controls. B: Serum ACE2 content (nM) was higher in the HRS group as compared with controls. C: Serum ACE:ACE2 ratios are lower in NRS and HRS groups as compared with controls. D: Serum DPP3 levels (nM) were higher in the NRS and HRS groups as compared with controls. Statistical comparisons by one-way ANOVA with Tukey’s ( A,B ) or Kruskal-Wallis ( C,D ) post hoc tests among all groups.

    Journal: Clinical science (London, England : 1979)

    Article Title: Higher circulating ACE2 and DPP3 but reduced ACE and angiotensinogen in hyperreninemic sepsis patients

    doi: 10.1042/CS20242168

    Figure Lengend Snippet: A: Serum ACE (nanomolar, nM) was lower in NRS and HRS groups as compared with controls. B: Serum ACE2 content (nM) was higher in the HRS group as compared with controls. C: Serum ACE:ACE2 ratios are lower in NRS and HRS groups as compared with controls. D: Serum DPP3 levels (nM) were higher in the NRS and HRS groups as compared with controls. Statistical comparisons by one-way ANOVA with Tukey’s ( A,B ) or Kruskal-Wallis ( C,D ) post hoc tests among all groups.

    Article Snippet: Specificity of the assays was assessed by the addition of the ACE inhibitor lisinopril and the ACE2 inhibitor MLN4760 (MedChem Express) as described [ 6 ].

    Techniques: Comparison

    In sepsis patients with high renins, inappropriate low levels of Ang II would stimulate renin release owing to loss of negative feedback (attenuated short feedback loop), as well as reduced blood pressure and increased sympathetic tone. Lower ACE but higher ACE2 and DPP3 may reduce circulating levels of Ang II. Higher Ang-(1-7) levels may reflect increased ACE2 but lower ACE that reduces metabolism of Ang-(1-7) to Ang-(1-5). Lower Ang II may also contribute to the reduced release of Aogen from the liver that may further suppress the Ang II response. Reduced expression of the AT 1 R and/or reduced signalling (−) in the kidney and liver of sepsis patients may also contribute to high renin levels (attenuated negative feedback) but reduced Aogen release into the circulation.

    Journal: Clinical science (London, England : 1979)

    Article Title: Higher circulating ACE2 and DPP3 but reduced ACE and angiotensinogen in hyperreninemic sepsis patients

    doi: 10.1042/CS20242168

    Figure Lengend Snippet: In sepsis patients with high renins, inappropriate low levels of Ang II would stimulate renin release owing to loss of negative feedback (attenuated short feedback loop), as well as reduced blood pressure and increased sympathetic tone. Lower ACE but higher ACE2 and DPP3 may reduce circulating levels of Ang II. Higher Ang-(1-7) levels may reflect increased ACE2 but lower ACE that reduces metabolism of Ang-(1-7) to Ang-(1-5). Lower Ang II may also contribute to the reduced release of Aogen from the liver that may further suppress the Ang II response. Reduced expression of the AT 1 R and/or reduced signalling (−) in the kidney and liver of sepsis patients may also contribute to high renin levels (attenuated negative feedback) but reduced Aogen release into the circulation.

    Article Snippet: Specificity of the assays was assessed by the addition of the ACE inhibitor lisinopril and the ACE2 inhibitor MLN4760 (MedChem Express) as described [ 6 ].

    Techniques: Expressing